comparison of glp 1 drugs glp-1 and gastric bypass Metabolic bariatric surgery versus glucagon-like peptide-1 receptor agonist therapy: A cardiovascular outcomes in patients with obesity Comparing GLP‑1 With Other – Bariatric Surgery vs Weight Loss

2022 Jun 26;14(13):2641

Emsley, P., Lohkamp, B., Scott, W

I read some research on parietal cell antibodies that correlated that people who had hypothyroidism, which we know a lot of people with gut issues also have thyroid issues, that people who had autoimmune hypothyroidism, or Hashimotos, would have about a 20 to 40% chance of having elevated parietal cell antibodies, meaning the immune system is attacking the parietal cells, which are the ones that are producing the stomach acid

In one comparison study, glutathione showed the strongest effect in inhibiting tyrosinase activity over free cysteine, chloride cysteine and kojic acid